Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Diet, Metabolism, and Disease, and Cancer Cells and Metastasis.
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis.
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis.
Intestinal blood vessel-associated macrophages and gut-vascular barrier dysfunction in cirrhosis
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation.
Reply to: "Diabetes-driven pathophysiological remodeling of mesenteric adipose tissue: Transcriptomic insights into macrophage infiltration and adipokine dyshomeostasis".
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH.
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Comparison of the single-cell and single-nucleus hepatic myeloid landscape within decompensated cirrhosis patients.
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Sublethal necroptosis signaling promotes inflammation and liver cancer
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.
Sublethal necroptosis signaling promotes inflammation and liver cancer.
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.